Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma - Sorbonne Université
Journal Articles JCO precision oncology Year : 2023

Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma

Duy Thanh Tran
Clovis Adam
  • Function : Author
Michèle Bernier
  • Function : Author
Dominique Cazals-Hatem
  • Function : Author
Karima Mokhtari
  • Function : Author
Bertrand Mathon
  • Function : Author
Laurent Capelle
  • Function : Author

Abstract

PURPOSE The Lynch syndrome (LS)-glioma association is poorly documented. As for mismatch repair deficiency (MMRd) in glioma, a hallmark of LS-associated tumors, there are only limited data available. We determined MMRd and LS prevalence in a large series of unselected gliomas, and explored the associated characteristics. Both have major implications in terms of treatment, screening, and prevention. METHODS Somatic next-generation sequencing was performed on 1,225 treatment-naive adult gliomas referred between 2017 and June 2022. For gliomas with ≥1 MMR pathogenic variant (PV), MMR immunohistochemistry (IHC) was done. Gliomas with ≥1 PV and protein expression loss were considered MMRd. Eligible patients had germline testing. To further explore MMRd specifically in glioblastomas, isocitrate dehydrogenase (IDH)-wild type (wt), we performed IHC, and complementary sequencing when indicated, in a series of tumors diagnosed over the 2007-2021 period. RESULTS Nine gliomas were MMRd (9/1,225; 0.73%). Age at glioma diagnosis was <50 years for all but one case. Eight were glioblastomas, IDH-wt, and one was an astrocytoma, IDH-mutant. ATRX (n = 5) and TP53 (n = 8) PV were common. There was no TERT promoter PV or EGFR amplification. LS prevalence was 5/1,225 (0.41%). One 77-year-old patient was a known LS case. Four cases had a novel LS diagnosis, with germline PV in MSH2 (n = 3) and MLH1 (n = 1). One additional patient had PMS2-associated constitutional mismatch repair deficiency. Germline testing was negative in three MSH6-deficient tumors. In the second series of glioblastomas, IDH-wt, MMRd prevalence was 12.5% in the <40-year age group, 2.6% in the 40-49 year age group, and 1.6% the ≥50 year age group. CONCLUSION Screening for MMRd and LS should be systematic in glioblastomas, IDH-wt, diagnosed under age 50 years.
Fichier principal
Vignette du fichier
MMR and LS in Gliomas RF clean.pdf (712.03 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-04115776 , version 1 (02-06-2023)

Identifiers

Cite

Patrick R Benusiglio, Fikret Elder, Mehdi Touat, Alexandre Perrier, Marc Sanson, et al.. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma. JCO precision oncology, 2023, 7, ⟨10.1200/PO.22.00525⟩. ⟨hal-04115776⟩
69 View
45 Download

Altmetric

Share

More